3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Classical hematology
1
CNS
1
Breast
1
Conditions
Leukemia, Myeloid, Acute
191
Anemia, Refractory, with Excess of Blasts
179
Myelodysplastic Syndromes
175
Leukemia
168
Precursor Cell Lymphoblastic Leukemia-Lymphoma
132
Neoplasms
121
Multiple Myeloma
116
Venous Thromboembolism
111
Anemia
108
Leukemia, Myelomonocytic, Chronic
103
Leukemia, Lymphocytic, Chronic, B-Cell
100
Myeloproliferative Disorders
99
Lymphoma, Non-Hodgkin
97
Lymphoma
96
Hodgkin Disease
85
Thrombocytopenia
84
Anemia, Aplastic
79
Primary Myelofibrosis
67
Lymphoma, Follicular
67
Hematologic Neoplasms
63
Leukemia, Myeloid, Chronic-Phase
61
Lymphoma, Mantle-Cell
59
Febrile Neutropenia
59
Congenital Abnormalities
59
Neoplasms, Plasma Cell
57
Leukemia, Myeloid, Accelerated Phase
57
Anemia, Refractory
57
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
56
Blast Crisis
56
Burkitt Lymphoma
53
Interventions
ziprasidone
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Tranexamic Acid
1
Tobramycin
1
Spironolactone
1
Sevelamer
1
Rocuronium
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Nifedipine
1
Nafcillin
1
Molindone
1
Methylprednisolone
1
Lurasidone Hydrochloride
1
Labetalol
1
Haloperidol
1
Fosfomycin
1
Clozapine
1
Ciprofloxacin
1
Cidofovir
1
Cefepime
1
Bosentan
1
Aminocaproic Acid
1
Amikacin
1
Alfentanil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Bradycardia
×
Classical hematology
×
Clear all
NCT01431326
2023-09-06
PTN_POPS
Duke University
Completed
3,520 enrolled